Statement on Glucagen Hypokit supply 2 August 2023 Novo Nordisk has notified the Therapeutic Goods Administration that the Glucagen Hypokit is currently in a shortage that will last until 30 September 2023. The Glucagen Hypokit is used to treat severe hypoglycaemia where a person is unconscious or unable to take oral hypo treatments. If a person has a severe hypo and you don’t have a Hypokit you need to call 000 immediately. Diabetes Australia is working with the diabetes sector and the TGA to ensure people at highest risk are prioritized access to available supply. The TGA have also activated Section 19A provisions and is arranging imports of Hypokits from other countries. If you have concerns please talk to someone from your diabetes healthcare team.
Blog 1 April 2026 Five less common reasons your glucose levels may be running high High glucose readings can feel frustrating, especially when you can’t see an obvious reason why. The reality is that many everyday factors such as stress, sleep, hormones and even hydration can all play a role. Continue Reading
Media releases 25 March 2026 Health Minister to deliver keynote address at National Diabetes Summit Federal Minister for Health and Ageing Mark Butler will deliver the keynote address at the National Diabetes Summit on 31... Continue Reading
News 19 March 2026 Support for people living with diabetes affected by cyclones Diabetes Australia extends its thoughts to the individuals, families, and communities affected by Tropical Cyclone Narelle in Far North Queensland. We recognise that natural disasters like cyclones can... Continue Reading
